Vaccines & Medications Targeting Alpha-Synuclein: Latest Parkinson’s Disease Research

New treatments for Parkinson’s disease Did you know that many pharmaceutical companies are working on vaccinations and other potential...see more new treatments for Parkinson’s disease (PD)?  Each clinical trial and study that is underway is teaching us something new and important that will hopefully get us closer to a successful outcome. Research into potential new medications […]

Read More

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

Exciting New Parkinson’s Disease Research is Underway On September 5, 2024, APDA announced 20 new Parkinson’s disease (PD) research...see more grants, for a total of $ 2.6 million in funding for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease (PD) and to develop new treatments and eventually, a […]

Read More

What We Know About Parkinson’s Disease in Women

Differences of Parkinson’s Disease in Women Parkinson’s disease (PD) impacts millions of people around the world, and it does...see more not discriminate based on gender. But while PD affects men and women with some similarities, the manifestation, progression, and even treatment responses can differ significantly between genders, in addition to important discrepancies related to healthcare access […]

Read More

Are there different types of Parkinson’s disease?

An Interview With ADPA Researcher, Dr. Abdulmunaim Eid About Parkinson’s Subtypes Our A Closer Look blog is designed to educate, inform,...see more and inspire you through a variety of topics and insights about Parkinson’s disease (PD). One way we do that is through our Interview with APDA Researchers series within this blog so you can get a closer look at […]

Read More

Tracking the Impact: 2023 APDA-funded Parkinson’s Research

APDA’s Impactful Research in Parkinson’s Disease APDA proudly invests in the most promising clinicians and scientific projects focused on...see more the discovery of the cause(s) and finding the cure(s) for Parkinson’s disease (PD). APDA is committed to scientific research and has been a funding partner in many major PD scientific breakthroughs, investing nearly $60 million in research […]

Read More

APDA Proudly Supports New 2023 – 2024 Parkinson’s Research

Exciting New Parkinson’s Research is Underway On September 7, 2023, APDA announced 20 new Parkinson’s disease (PD) research grants,...see more for a total of $1.975 million in funding for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease (PD) and to develop new treatments and eventually, a cure. We […]

Read More

Hope in Progress: American Parkinson Disease Association Supports Researchers With $1.975 Million in New Funding

From understanding levodopa induced dyskinesias to exploring environmental risk factors of PD, APDA-funded researchers pursue cutting-edge studies NEW YORK,...see more NY, September 7, 2023 – The American Parkinson Disease Association (APDA) has just awarded $1.975 million to support innovative Parkinson’s disease (PD) research for the 2023-2024 funding year. The funded research projects will delve into key […]

Read More

Diversity in Parkinson’s Disease Research Grant

Diversity in Parkinson’s Disease Research Grant: Academic Year 2025-2026 Letter of Intent due: Dec 16, 2024. Invitation for full...see more application: Early February 2025 Full Application due: April 2025 Award details One year grant up to a maximum of $75,000 will be awarded to research scientists (MD, MD/PhD, or PhD). The applicants will receive notification of […]

Read More

Where are they now? Past APDA Research Grant Awardees

Advancing Scientific Breakthroughs and Empowering Parkinson’s Disease Research Since 1961, APDA has been a funding partner in many major...see more scientific breakthroughs and has awarded more than $60 million in research grants to date. APDA awards individual research grants and fellowships to scientists performing innovative Parkinson’s disease (PD) research. Grantees are selected through a competitive application […]

Read More

Trichloroethylene and Parkinson’s Disease Risk

TCE and Parkinson’s disease risk Like most chronic diseases, the chance of developing Parkinson’s disease (PD) is due to...see more an accumulation of both genetic and environmental risk factors. Researchers are working to identify as many of these risk factors as possible as well as to understand what causes a person to develop Parkinson’s. For many […]

Read More